Michael Exton insider trades
Open-market stock purchases and sales by Michael Exton, Chief Executive Officer at Lexicon Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 8, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 28, 2026 | LXRX Lexicon Pharmaceuticals, Inc | Sold (not open market) | $301K |
| Feb 28, 2026 | LXRX Lexicon Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 12, 2026 | LXRX Lexicon Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 12, 2026 | LXRX Lexicon Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- LXRX Lexicon Pharmaceuticals, Inc: other filings, last Feb 28, 2026